Jennifer L. McNeer to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Jennifer L. McNeer has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
4.406
-
Updates in Childhood Acute Lymphoblastic Leukemia. Hematol Oncol Clin North Am. 2026 06; 40(3):331-346.
Score: 0.697
-
Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep. 2022 02; 17(1):1-14.
Score: 0.514
-
How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S8-S11.
Score: 0.468
-
Cutting to the Front of the Line: Immunotherapy for Childhood Acute Lymphoblastic Leukemia. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-12.
Score: 0.452
-
Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults. Pediatr Blood Cancer. 2018 06; 65(6):e26989.
Score: 0.392
-
Acute lymphoblastic leukemia in young adults: which treatment? Curr Opin Oncol. 2012 Sep; 24(5):487-94.
Score: 0.269
-
The complex interplay between folate metabolism and risk of acute lymphoblastic leukemia. Leuk Lymphoma. 2011 Sep; 52(9):1621-2.
Score: 0.248
-
The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol. 2010 Jun; 149(5):638-52.
Score: 0.228
-
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. Blood Adv. 2026 07 28; 10(14):4923-4930.
Score: 0.176
-
American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults. Blood Adv. 2026 Jul 14; 10(13):4671-4708.
Score: 0.176
-
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2022 11; 69(11):e29937.
Score: 0.135
-
MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia. Leuk Lymphoma. 2022 06; 63(6):1436-1444.
Score: 0.129
-
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. Cancer Med. 2021 11; 10(21):7551-7560.
Score: 0.126
-
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. Blood Adv. 2021 01 26; 5(2):504-512.
Score: 0.120
-
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leuk Lymphoma. 2018 10; 59(10):2360-2368.
Score: 0.098
-
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leuk Lymphoma. 2017 04; 58(4):950-958.
Score: 0.090
-
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study. Cancer. 2017 Jan 01; 123(1):122-130.
Score: 0.089